Enzymatic and non-enzymatic reduction of brucine N -oxide by aldehyde oxidase and catalase

References

• BEEDHAM, C., 1985, Molybdenum hydroxylases as drug-metabolizing enzymes. Drug Metabolism Reviews, 16, 119–156.
   PubMed Web of Science ®Google Scholar
• BICKEL, M. H., 1969, The pharmacology and biochemistry of N-oxides. Pharmacological Reviews, 21, 325–355.
   PubMed Web of Science ®Google Scholar
• CLEMENT, B. and DEMESMAEKER, M., 1997, Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2. Drug Metabolism and Disposition, 25, 1266–1271.
   PubMed Web of Science ®Google Scholar
• CLEMENT, B. and JUNG, F., 1994, N-hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Drug Metabolism and Disposition, 22, 486–497.
   PubMed Web of Science ®Google Scholar
• CLEMENT, B., Lonis, R. and MDLLER, W., 1997, Isolation and characterization of the protein components of the liver microsomal 02-insensitive NADH-benzamidoxirne reductase. Journal of Biological Chemistry, 272, 19615–19620.
   PubMed Web of Science ®Google Scholar
• CLEMENT, B., SCHULTZE-MOSGAU, M. H., RICHTER, P. H. and BESCH, A., 1994, Cytochrome P450-dependent N-hydroxylation of an aminoguianidine (amidinohydrazone) and microsomal retroeduction of the N-hydroxylated product. Xenobiotica, 24, 671–688.
   Google Scholar
• CLEMENT, B., SCHULTZE-MOSGAU, M. H. and WOHLERS, H., 1993, Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and futher oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Biochemical Pharmacology, 46, 2249–2267.
   Google Scholar
• CRICHTON, R. R., ROMAN, F. and WAUTERS, M., 1975, Reductive mobilization of ferritin iron by reduced micotinamide-adenine dinucleotide flavin mononucleotide. Biochemical Society Transactions, 3, 946–948.
   Google Scholar
• DAMANI, L. A., 1982, Oxidation at nitrogen centers. In W. B. Jakoby, J. R. Bend and J. Caldwell (eds), Metabolic Basis of Detoxication (New York: Academic Press), pp. 127–149.
   Google Scholar
• FELSTED, R., Cliu, A.E.-Y. and CHAYKIN, S., 1973, Purification and properties of the aldehyde oxidases from hog and rabbit livers. Journal of Biological Chemistry, 248, 2580–2587.
   Google Scholar
• GILLESPIE, S. G. and DUFFEL, M.W., 1989, Peroxidase as a model for reduction of tertiary amine oxides catalyzed by rat hepatic supernatant and microsomal fractions. Biochemical Pharmacology, 38, 573–579.
   PubMedGoogle Scholar
• GINGELL, R. and WALKE R., 1971, Mechanisms of azo reduction by Streptococcus faecalis. II. The role of soluble flavins. Xenobiotica, 1, 231–239.
   PubMedGoogle Scholar
• IwAsAiti, K., Nouucin, H., KATO, R., ImAi, Y. and SATO, R., 1977, Reduction of tertiary amine N-oxide by purified cytochrome P-450. Biochemical and Biophysical Research Communications, 77, 1143–1149.
   PubMedGoogle Scholar
• Kamm, J. J. and GILLETTE, J. R., 1963, Mechanism of stimulation of mammalian nitro reductase by flavins. Life Sciences, 4, 254–260.
   Google Scholar
• KIESE, M., RENNER, G. and SCHLAEGE R., 1971, Mechanism of the autocatalytic formation of ferrihemoglobin by N,N-dimethylaniline N-oxide. Naunyn-Schmiedebergs Archives of Pharmacology, 268, 247–263.
   PubMedGoogle Scholar
• KITAMURA, S., KUWASAKO, M., SUGIHARA, K. and TATSUMI, K., 1999a, Debromination of ct-(bromoisovaleryl)urea catalyzed by rat blood. Journal of Pharmacy and Pharmacology, 51, 73–78.
   PubMedGoogle Scholar
• KITAMURA, S., SUGIHARA, K. and TATSUMI, K., 1999b, A unique tertiary amine N-oxides reduction system composed of quinone reductase and heme in rat liver preparations. Drug Metabolism and Disposition, 27, 92–97.
   PubMed Web of Science ®Google Scholar
• KITAMURA, S., TAKEKAWA, K., SUGIHARA, K., TATSUMI, K. and OHTA, S., 1999c, Pseudoenzymatic reduction of N-hydroxy-2-acetylaminofluorene to 2-acetylaminofluorene mediated by cytochrome P450. Carcinogenesis, 20, 347–350.
   PubMedGoogle Scholar
• KITAMURA, S. and TATSUMI, K., 1984a, Inolvement of liver aldehyde oxidase in the reduction of nicotinamide N-oxide. Biochemical and Biophysical Research Communications, 120, 602–606.
   PubMed Web of Science ®Google Scholar
• KITAMURA, S. and TATSUMI, K., 1984b, Reduction of tertiary amine N-oxides by liver preparations: function of aldehyde oxidase as a major N-oxide reductase. Biochemical and Biophysical Research Communications, 121, 749–754.
   PubMed Web of Science ®Google Scholar
• KITAMURA, S., WADA, Y. and TATSUMI, K., 1984, NAD(P)H-dependent reduction of nicotinamide N-oxide by unique enzyme system consisting of liver micro somal NADPH-cyto chrome c reductase and cytosolic aldehyde oxidase. Biochemical and Biophyscial Research Communications, 125, 1117–1122.
   PubMed Web of Science ®Google Scholar
• LOWRY, 0.H., ROSEBROUGH, N. J., FAR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• PArrEasoN, L. H. and GORROD, J. W., 1978, The metabolism of some 4-substituted N-ethyl-N-methylaniline N-oxides. In J. W. Gorrod (ed.), Biological Oxidation of Nitrogen (Amsterdam: Elsevier), pp. 471–478.
   Google Scholar
• PHILLIPSON, J. D., 1971, Alkaloid N-oxides. Xenobiotica, 1, 419–447.
   PubMedGoogle Scholar
• PHILLIPSON, J. D. and HANDA, S. S., 1978, Alkaloid N-oxides. A review of recent developments. Lloydia, 41, 385–431.
   PubMedGoogle Scholar
• Powis, G. and DE GRAW, C. L., 1980, N-Oxide reduction by hemoglobin, cytochrome c and ferrous ions. Research Communications in Chemical Pathology and Pharmacology, 30, 143–150.
   PubMedGoogle Scholar
• Powls, G., SVINGEN, B. A. and DE GRAW, C., 1982, Iron-EDTA simulated reduction of indicine N-oxide by hepatic microsomal fraction, isolated hepatocytes, and the intact rat. Biochemical Pharmacology, 31, 293–299.
   PubMedGoogle Scholar
• Powis, G. and WINCENTSEN, L., 1980, Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-450. Biochemical Pharmacology, 29, 347–351.
   PubMed Web of Science ®Google Scholar
• RENNER, G., 1975, Reactions of 4-halogeno-N,N-dimethylaniline-N-oxide with hemoglobin. Naunyn- Schmiedebergs Archives of Pharmacology, 291, 31–45.
   PubMedGoogle Scholar
• SINGER, T. P. and KEARNEY, F. B., 1950, The non-enzymatic reduction of cytochrome c by pyridine nucleotides and its catalysis by various flavins. Journal of Biological Chemistry, 183, 409–429.
   Google Scholar
• SUGIHARA, K., KITAMURA, S. and OHTA, S., 1998, Reductive dechlorination of DDT to DDD by rat blood. Biochemistry and Molecular Biology International, 45, 85–91.
   PubMedGoogle Scholar
• SUGIHARA, K., KITAMURA, S., OHTA, S. and TATSUMI, K., 2000, Reduction of hydroxamic acids to the corresponding amides catalyzed by rabbit blood. Xenobiotica, 30, 457–467.
   PubMed Web of Science ®Google Scholar
• SUGIHARA, K., KITAMURA, S. and TATSUMI, K., 1996, S-(—)-nicotine-1' -N -oxide reductase activity of rat liver aldehyde oxidase. Biochemistry and Molecular Biology International, 40, 535–541.
   PubMedGoogle Scholar
• SUGIURA, M., IwAsAKI, K. and KATO, R., 1976, Reduction of tertiary amine N-oxides by liver microsomal cytochrome P-450. Molecular Pharmacology, 12, 322–334.
   PubMed Web of Science ®Google Scholar
• TAKEKAWA, K., KITAMURA, S., SUGHIHARA, K. and OHTA, S., 2001, Non-enzymatic reduction of aliphatic tertiary amine N-oxides mediated by the haem moiety of cytochrome P450. Xenobiotica, 31, 11–23.
   PubMed Web of Science ®Google Scholar
• TERAYAMA, H., 1963. Aminoazo dye amine-N-oxide as a possible intermediate metabolite preceding N-demethylation and ortho-hydroxylation, as well as azo dye-protein binding. Gann, 55, 195–204.
   Google Scholar
• VAISEY, E. B., 1956, The non-enzymic reduction of trirnethylamine oxide to treimethylamine, dirnethylamine, and formaldehyde. Canadian Journal of Biochemistry and Physiology, 34, 1085–1090.
   PubMedGoogle Scholar
• YUBISUI, T., MATSUKAWA, S. and YONEYAMA, Y., 1980, Stopped flow studies on the nonenzymatic reduction of methemoglobin by reduced flavin mononucleotide. Journal of Biological Chemistry, 255, 11694–11697.
   PubMedGoogle Scholar
• YUBISUI, T., MATSUKI, T., TANISHIMA, K., TAKESHITA, M. and YONEYAMA, Y., 1977, NADPH-flavin reductase in human erythrocytes and the reduction of methemoglobin through flavin by the enzyme. Biochemical and Biophysical Research Communications, 76, 174–182.
   PubMedGoogle Scholar
• YUBISUI, T. and TAKESHITA, M., 1980, Characterization of the purified NADH-cytochrome b5 reductase of human erythrocytes as a FAD-containing enzyme. Journal of Biological Chemistry, 255, 2454–2456.
   PubMedGoogle Scholar
• ZIEGLER, D. M., 1980, Microsomal flavin-containing monooxygenase. In W. B. Jakoby (ed.), Enzymatic Basis of Detoxication I (New York: Academic Press), pp. 201–227.
   Google Scholar